Member Info for draft

could this go as big as serica? also there's no way Michael spencer ipgl would let themselves get diluted here surely they've been putting too much in to allow cluff to get away with a shitty placing. cluff does need to get a deal on these licences though. doubt they'd been allowee tl drag this on if nothing in pipeline.

global marketplace is a feeding frenzy on AI right now

The medical technology centres in Leeds, Oxford, Coventry, Glasgow and London will be funded by the Government as it looks to increase its investment in AI and improve patient treatment. The centres will use AI software to digitalise scans and biopsies, and develop products to detect diseases early. The large investment, costing £50million, will ensure people get personalised treatment sooner, as well as freeing up doctors time. +2 The Government has announced £50million investment in artificial intelligence-powered medical centres to cut down diagnosis time (stock) Business, Energy and Industrial Strategy Secretary Greg Clark said: 'AI has the potential to revolutionise healthcare and improve lives for the better.' 'The innovation at these new centres will help diagnose disease earlier to give people more options when it comes to their treatment, and make reporting more efficient, freeing up time for our much-admired NHS staff to spend on direct patient care.' The new centres, which will be based at universities and NHS facilities, are expected to open during 2019. 3shares RELATED ARTICLESHealth Secretary Matt Hancock is accused of aiming for a 'nanny state' with plans for bedside interventions and teaching people to be healthyHealth Secretary will unveil plans for personalised warnings based on social class, lifestyle and genetics in bid to help Britons live an extra five years DR MICHAEL MOSLEY: I'm worried Artificial Intelligence could make us stupidDoctors could use AI to diagnose DEMENTIA after scientists train computers to recognise the memory-robbing disorder Health and Social Care Secretary Matt Hancock said: 'Artificial intelligence will play a crucial role in the future of the NHS and we need to embrace it by introducing systems which can speed up diagnoses, improve patient outcomes, make every pound go further and give clinicians more time with their patients. 'As part of our long-term plan, we will transform the NHS into an ecosystem of enterprise and innovation that allows technology to flourish and evolve.' Mr Hancock recently launched a vision to build 'the most advanced health and care system in the world', by transforming NHS technology. Outdated and obstructive NHS IT systems will become a thing of the past, he said in The Future of Healthcare. He said: 'The tech revolution is coming to the NHS. These robust standards will ensure that every part of the NHS can use the best technology to improve patient safety, reduce delays and speed up appointments.' His vision looks at AI to help diagnose disease and gain better insights into treatments and prevention, as well as using robots to support people, and their carers, in rehabilitation, dementia support or medication management'. The advance in technology could also take over the communication of patients' notes, booking of appointments and processing of prescriptions. ADVERTISEMENT These will build on the £2

https://www.dailymail.co.uk/health/article-6356705/Five-new-AI-medical-centres-speed-disease-diagnosis.html

well be interesting if stone checker can go on to predict kidney damage

Artificial intelligence medical imaging diagnostics startup Visla Labs announced today that it has raised $3 million in seed funding. The round was led by Lux Capital, with participation from others including Dick Costolo and Adam Bain, Twitter’s former CEO and COO, respectively. The startup’s first software offering uses AI to increase the accuracy, speed and cost of radiology diagnoses. Founded in 2018 by Stanford, Apple and Twitter vets, the company said in a statement that early versions of its technology are currently employed by over 30 locations in the US and Asia. Visla said that it plans to use these new funds to expand its team, scale product features and pursue regulatory approval. Why it matters Automated diagnoses from medical images across a number of specialties is a clear and growing use case for AI due to its potential to cut costs and reduce specialist demand. Today’s funding and the widespread early use of Visla’s radiology-focused tool suggest that interest in the technology is rising.

moves into AI.

Amid a whirlwind of increasing medical and safety concerns, South Korea has decided to ban its use of gadolinium MRI dye taking effect at the end of 2018. Regulators in South Korea have decided to make this announcement over recent apprehensions that the dye might accumulate in the brain. Meanwhile, lawsuits filed in federal courts in the United States continue to accumulate. The gadolinium MRI dye ban affects linear agents such as Magevist, Optimark, and Omniscan, plus 13 others. In addition to other international localities raising their concerns over the dyes, European regulators have also suspended their use over similar concerns. Yet, countries such as Canada, Japan, Switzerland, and the United States still allow the use of gadolinium MRI contrast dyes.

MCAP comparison company product mcap listed sp Renalytix AI Kidney £63m aim 121p Scientific Digital All £37m aim 42p Polarean Lung £13m aim 17p Ixico Brain £12m aim 26p Feedback Lung £5m aim 1.6p IQ-AI Brain, Kidney £3m Standard list 2.5p

Cluff just did a BP tweet

this is main market. very undervalued. David Smith COO sold his previous firm for 168 million usd. we are in Lamborghini territory here.

serious potential here.

https://www.cbc.ca/news/canada/calgary/university-calgary-kidney-research-1.4861796

BetVictor is a huge deal - this share is at rock Bottom, GAN £44million market cap. This is £9mill mcap.

The metric raise in the US is 50% of NKTNS market cap.

We really could see £1 here in my opinion

agree CityAL. i will certainly be taking a few more over next 3 months hopefully. power is with the Wind industry.

A recruiting campaign has kicked off on the Isle of Wight in the UK as MHI Vestas Offshore Wind looks to keep pace with growing demand for its V164 wind turbine platform.

MHI Vestas Blades UK production director James Luter said “Today marks the start of an ambitious programme to increase the capacity of our blade production facility at the West Medina Mills on the Isle of Wight. We are looking for people with the right attitude, a good work ethic and who want to be part of something historic.

“Building the world’s largest serially-produced wind turbine blades right here on the island, we are helping to move the world toward clean energy, so we can’t wait to welcome our new employees who join us on this journey.”

With more than 300 people already employed at the blade manufacturing facility at West Medina Mills Stag Lane, MHI Vestas said it will offer newcomers “an attractive salary and benefits package and a very strong training programme.” And the recruiting timetable is tight.

Mr Luter continued, “This is an ambitious ramp up. We have an exceptionally strong, inhouse training programme.”

MP for Isle of Wight Bob Seely said, “This is great news for the island and a major vote of confidence in our people and industry by the clean energy business, MHI Vestas. Their ambitious programme to recruit hundreds of skilled, long-term roles over the next few months confirms the island’s pivotal role within the wider Solent region, which is fast becoming a hub for the world’s offshore wind turbine industry.”

The expansion plans at MHI Vestas include the procurement of a second mould for blade manufacture, which is subsequent to submission of an application for partial funding of the procurement.

the Company has experienced a significant increase in the level of interest in the Company's licences and has welcomed a number of new parties, including established North Sea operators, into its data room. While providing these new entrants sufficient time to evaluate the opportunities available, the Company is continuing discussions with several parties who have previously indicated an interest in the assets.  ill be astonished if this goes south

recently updated the UK Oil and Gas Authority ("OGA") on its farm out processes for the P2248 and P2252 licences. As a result, the OGA is not proposing to enforce the previously stated milestone whereby a drill or drop decision was needed to be made by 30 September 2018. Accordingly, both the Promote Period and the Initial Term of both licences will continue to run until 30 November 2018. we must be close then. 30th Nov aint far away. New people in data room. forget bagging im going for 10p minimum here.

i havent heared anything. its in the last rns. the oga extended cluffs 2 licences again after cluff explained to them they are close to a deal. the rns says that. think mid november is mentioned in rns.

https://www.thecourier.co.uk/fp/news/local/perth-kinross/740891/aviva-plan-to-build-77-metre-high-wind-turbine-at-perth-plant/amp/?__twitter_impression=true

Aviva planning massive 77 metre high wind turbine at Perth.